Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Gilead and Arcus’ TIGIT combo continues to show signs of life
Gilead and Arcus are continuing to stake out their claim to the anti-TIGIT market, posting updated phase 2 data at ASCO.
Max Bayer
Jun 3, 2023 1:30pm
BioNTech’s $200M bet on next-gen Yervoy triggers tumor responses
Jun 2, 2023 10:00am
Medtronic names ex-Amazon exec first tech and innovation chief
Jun 2, 2023 9:51am
Eikon builds out clinical development team—Chutes & Ladders
Jun 2, 2023 9:30am
Facing bankruptcy, Oncorus lays off 'substantially' all staff
Jun 2, 2023 8:21am
AI is helping find new antibiotics. Can they get to the clinic?
Jun 2, 2023 6:00am
Research News
Small biotech turns CRISPR against bacteria
May 31, 2023 10:50am
Calling all Alzheimer's patients: a study out there needs you
May 31, 2023 10:00am
Brain-spine interface helps man with paralysis walk again
May 26, 2023 9:20am
PD-1 R&D tapers off as new molecules capture interest: IQVIA
May 24, 2023 2:09pm
See More Research News